Rollercoaster of Hospital COVID Drug Spending Continued in 2022
According to the National Trends in Prescription Drug Expenditures and Projections for 2023 report by the American Society of Health System Pharmacists (ASHP), the primary reason for a 5.2% decline in hospital drug spending last year was the sudden drop in the use of COVID drug remdesivir compared to the previous year. In contrast, overall drug expenditures grew by 9.4% in 2022 in the U.S., reaching a total of $633.5 billion, with utilization increasing by 5.9% compared to 2021. Average drug pri